Vaccine Trials
-
{
- All
- News
- Videos
-
Trials Of 2 Ebola Treatments To Start In Congo Next Week: WHO
Trials of two separate potential treatments to fight the deadly Ebola outbreak in the Democratic Republic of Congo are expected to begin next week, according to the WHO.
-
Ebola Vaccine Race Intensifies With Fund Surge, But Doctors Also Suggest Caution
There have been recent funding announcements which have created optimism among scientists and health officials. Several vaccine candidates are now moving through different stages of development.
-
UP Man Asks Russia To Conduct Cancer Vaccine Trial On His 21-Year-Old Son
The Russian government took a sensitive stand on the appeal of Manu Srivastava of Lucknow to save the life of his 21-year-old son Ansh Srivastava, who is suffering from cancer.
-
Bill Gates Calls India A "Kind Of Laboratory To Try Things", Faces Backlash
Microsoft co-founder Bill Gates has landed in hot water after referring to India as "a kind of laboratory to try things" during a podcast with LinkedIn co-founder Reid Hoffman.
-
British Indian Doctor To Undertake "Ground-Breaking" Cancer Vaccine Trial
A British Indian doctor is the chief investigator of a "ground-breaking" trial of a vaccine to treat early bowel cancer for patients worldwide, following a UK-Australia collaboration between scientists and doctors.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
Roche Joins Moderna To Include Antibody Test In COVID-19 Vaccine Trial
Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially demonstrating if the vaccine is working.
-
Drug Authority Says Reaction In Volunteer Not Linked To Covid Vaccine: Report
A probe initiated by the Drugs Controller General of India (DCGI) into an alleged "serious adverse event" reportedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai has found that it was not related to the shot administered to him, official sources said.
-
Trials Of 2 Ebola Treatments To Start In Congo Next Week: WHO
Trials of two separate potential treatments to fight the deadly Ebola outbreak in the Democratic Republic of Congo are expected to begin next week, according to the WHO.
-
Ebola Vaccine Race Intensifies With Fund Surge, But Doctors Also Suggest Caution
There have been recent funding announcements which have created optimism among scientists and health officials. Several vaccine candidates are now moving through different stages of development.
-
UP Man Asks Russia To Conduct Cancer Vaccine Trial On His 21-Year-Old Son
The Russian government took a sensitive stand on the appeal of Manu Srivastava of Lucknow to save the life of his 21-year-old son Ansh Srivastava, who is suffering from cancer.
-
Bill Gates Calls India A "Kind Of Laboratory To Try Things", Faces Backlash
Microsoft co-founder Bill Gates has landed in hot water after referring to India as "a kind of laboratory to try things" during a podcast with LinkedIn co-founder Reid Hoffman.
-
British Indian Doctor To Undertake "Ground-Breaking" Cancer Vaccine Trial
A British Indian doctor is the chief investigator of a "ground-breaking" trial of a vaccine to treat early bowel cancer for patients worldwide, following a UK-Australia collaboration between scientists and doctors.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
Roche Joins Moderna To Include Antibody Test In COVID-19 Vaccine Trial
Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially demonstrating if the vaccine is working.
-
Drug Authority Says Reaction In Volunteer Not Linked To Covid Vaccine: Report
A probe initiated by the Drugs Controller General of India (DCGI) into an alleged "serious adverse event" reportedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai has found that it was not related to the shot administered to him, official sources said.
